Paper36046479
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Seidel MG and 9 others. Front Pediatr, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents. Papers, record 36046479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36046479
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32504042 | Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing. | Nat Commun | 2020 | https://conductscience.org/library/papers/32504042 | PubMed |
| 2 | 30410101 | Current and future perspectives of liquid biopsies in genomics-driven oncology. | Nat Rev Genet | 2019 | https://conductscience.org/library/papers/30410101 | PubMed |
| 3 | 27328849 | Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. | Nat Commun | 2016 | https://conductscience.org/library/papers/27328849 | PubMed |
| 4 | 33248210 | Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33248210 | PubMed |
| 5 | 21221095 | Integrative genomics viewer. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21221095 | PubMed |
| 6 | 24314616 | Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/24314616 | PubMed |
| 7 | 29056344 | Comprehensive Analysis of Hypermutation in Human Cancer. | Cell | 2017 | https://conductscience.org/library/papers/29056344 | PubMed |
| 8 | 29535149 | SvABA: genome-wide detection of structural variants and indels by local assembly. | Genome Res | 2018 | https://conductscience.org/library/papers/29535149 | PubMed |
| 9 | 35022204 | Hallmarks of Cancer: New Dimensions. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35022204 | PubMed |
| 10 | 32466770 | CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data. | Genome Biol | 2020 | https://conductscience.org/library/papers/32466770 | PubMed |
| 11 | 27351911 | Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. | Cancer | 2016 | https://conductscience.org/library/papers/27351911 | PubMed |
| 12 | 32968207 | Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond. | Br J Cancer | 2021 | https://conductscience.org/library/papers/32968207 | PubMed |
| 13 | 20547982 | Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20547982 | PubMed |
| 14 | 23770567 | Mutational heterogeneity in cancer and the search for new cancer-associated genes. | Nature | 2013 | https://conductscience.org/library/papers/23770567 | PubMed |
| 15 | 33326092 | Liquid Biopsies in Ewing Sarcoma. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/33326092 | PubMed |
| 16 | 34050156 | Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. | Nat Commun | 2021 | https://conductscience.org/library/papers/34050156 | PubMed |
| 17 | 26308893 | A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. | Nature | 2015 | https://conductscience.org/library/papers/26308893 | PubMed |
| 18 | 30027144 | Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. | JCO Precis Oncol | 2018 | https://conductscience.org/library/papers/30027144 | PubMed |
| 19 | 30614191 | Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies. | Pediatr Blood Cancer | 2019 | https://conductscience.org/library/papers/30614191 | PubMed |
| 20 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42581900 | Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review. | Explor Target Antitumor Ther | 2026 | https://conductscience.org/library/papers/42581900 | PubMed |
| 42505381 | Signals Alongside Scans: A Genomics-Guided Framework for Liquid Biopsy in Bone and Soft-Tissue Sarcomas. | Cells | 2026 | https://conductscience.org/library/papers/42505381 | PubMed |
| 42437510 | Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application. | J Surg Oncol | 2026 | https://conductscience.org/library/papers/42437510 | PubMed |
| 42284698 | Analysis of cell-free DNA in lymphomas: from sample collection to genotyping and minimal residual disease monitoring. | Blood Adv | 2026 | https://conductscience.org/library/papers/42284698 | PubMed |
| 42220429 | Circulating Tumor DNA and microRNA-Based Liquid Biopsy for Longitudinal Treatment Monitoring and Recurrence Prediction in Pediatric Sarcomas: A Prospective Cohort Study. | Oncol Res | 2026 | https://conductscience.org/library/papers/42220429 | PubMed |
| 42003932 | Biological basis and clinical translation prospects of circulating cell-free DNA in precision management of breast cancer (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42003932 | PubMed |
| 41685600 | Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/41685600 | PubMed |
| 41602395 | The role of circulating tumor DNA in gynecological cancer management. | Front Oncol | 2025 | https://conductscience.org/library/papers/41602395 | PubMed |
| 40576756 | Interrupted Systemic Therapy (Drug Holiday) for Metastatic Sarcoma: Is It Safe? | Curr Treat Options Oncol | 2025 | https://conductscience.org/library/papers/40576756 | PubMed |
| 40149373 | Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent Advances. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149373 | PubMed |
| 39797974 | Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review. | Arch Orthop Trauma Surg | 2025 | https://conductscience.org/library/papers/39797974 | PubMed |
| 39760332 | Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma. | Cancer Res Commun | 2025 | https://conductscience.org/library/papers/39760332 | PubMed |
| 39737274 | Monitoring Response Using Circulating Tumor DNA in Undifferentiated Pleomorphic Sarcoma: A Case Report. | Cureus | 2024 | https://conductscience.org/library/papers/39737274 | PubMed |
| 39715595 | New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas. | Oncol Res Treat | 2025 | https://conductscience.org/library/papers/39715595 | PubMed |
| 39456239 | Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456239 | PubMed |
| 39097671 | A comprehensive overview of liquid biopsy applications in pediatric solid tumors. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39097671 | PubMed |
| 37905766 | [Research progress on circulating tumor DNA as a biomarker for minimal residual disease in solid tumors]. | Zhongguo Dang Dai Er Ke Za Zhi | 2023 | https://conductscience.org/library/papers/37905766 | PubMed |
| 37152023 | Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors. | Front Oncol | 2023 | https://conductscience.org/library/papers/37152023 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36046479
GET https://conductscience.org/api/papers/v1/36046479/references?page=2